Research Article
Efficacy of Subcutaneous Adipose Tissue Mesenchymal Stem Cell Therapy in Lichen Sclerosus: A Comprehensive Case Report Analysis
Received Date: June 05, 2024; Published Date: June 18, 2024
Abstract
Lichen sclerosus (LS) presents a therapeutic challenge due to its chronic inflammatory nature, leading to sclerosis and atrophy, primarily affecting the anogenital region. Despite advancements in conventional therapies, sustained remission remains elusive. Stem cell therapy, particularly using subcutaneous adipose tissue-derived mesenchymal stem cells (AD-MSCs), shows promise due to their regenerative and immunomodulatory properties. This comprehensive case report examines the therapeutic efficacy of AD-MSC therapy in LS management through detailed clinical and histological analyses of 22 patients with moderate to severe LS.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
